Publications by authors named "Brian G Topp"

Claim this Profile
E
Estimating efficacy of favezelimab plus pembrolizumab relative to pembrolizumab in anti-PD-1-refractory Hodgkin lymphoma.
Philippe Armand, Pier Luigi Zinzani, John Timmerman, Nathalie A Johnson, David Lavie, Brian G Topp

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor dynamics in patients with solid tumors treated with pembrolizumab beyond disease progression.
Brian G Topp, Madhav Channavazzala, Kapil Mayawala, Dinesh P De Alwis, Eric Rubin

Cancer Cell· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of the relationship between glycemia and beta-cell mass adaptation in vivo.
Laura L Atkinson, Brian G Topp, Jenny Au, Horatiu V Vinerian, Narinder Dhatt

Can J Physiol Pharmacol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with sitagliptin or metformin does not increase body weight despite predicted reductions in urinary glucose excretion.
Steven B Waters, Brian G Topp, Scott Q Siler, Charles M Alexander

J Diabetes Sci Technol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of insulin sensitivity, -cell function, and -cell mass during the development of diabetes in fa/fa rats.
Brian G Topp, Laura L Atkinson, Diane T Finegood

Am J Physiol Endocrinol Metab· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
beta-cell deterioration - prospects for reversal or prevention.
Diane T. Finegood, Brian G. Topp

Diabetes Obes Metab· August 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis